- Home
- /
- Treatment
- /
- Page 84
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Cabozantinib | Papillary thyroid cancer | Exelixis, Inc.;210 East Grand Avenue;South San Francisco, California, 94083 | November 29, 2010 | |
Filociclovir | Active cytomegalovirus infections | Microbiotix, Inc.;One Innovation Drive;Worcester, Massachusetts, 01605 | November 29, 2010 | |
Ganitumab | Pancreatic cancer | Nantcell;9920 Jefferson Blvd;Culver City, California, 90232 | November 23, 2010 | |
Cyclosporine; ciclosporin | Moderate to severe traumatic brain injury | NeuroVive Pharmaceutical AB;Medicon Village, SE-223 81;Lund | November 23, 2010 | |
Bevacizumab | Fallopian tube cancer | Genentech, Inc;1 DNA Way, M/S# 355E;South San Francisco, California, 94080 | November 23, 2010 | |
FliC Flagellin Deletion Variant TLR5 Agonist | Prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster | Cleveland BioLabs, Inc.;73 High Street;Buffalo, New York, 14203 | November 23, 2010 | |
Anti-insulin-like type 1 receptor immunoglobulin 1 | Pancreatic cancer | Amgen;One Amgen Center Drive;Thousand Oaks, CA, 91320-1799 | November 23, 2010 | |
Antihemophilic factor (recombinant), Fc fusion protein | Hemophilia A | Bioverativ Therapeutics, Inc.;225 2nd Avenue;Waltham, Massachusetts, 02451 | November 23, 2010 | |
4-pyridinylmethyl 3(4-chlorophenyl)adamantine carboxamide | Pancreatic cancer | Apogee Biotechnology Corporation;Hershey Center for Applied Research, Suite 1016;Hummelstown, Pennsylvania, 17036 | November 2, 2010 | |
Bevacizumab | Primary peritoneal carcinoma | Genentech, Inc;1 DNA Way, M/S# 355E;South San Francisco, California, 94080 | November 2, 2010 | |
Phosphatidylinositol 3-Kinase “PI3K” Inhibitor | Chronic lymphocytic leukemia | Semafore Pharmaceuticals;17338 Westfield Park Road, Suite 3;Westfield, Indiana, 46074 | November 2, 2010 | |
Chloropyramine | Pancreatic Cancer | CurFAKtor Pharmaceuticals, LLC;14 Rock Dove Lane;Orchard Park, New York, 14127 | October 22, 2010 | |
5-((4-(6-chlorothieno[2,3-d]pyrimidine-4-ylamino)piperidin-1-yl)methyl)-2-fluorobenzonitrile monofumurate | Pulmonary Arterial Hypertension | Forest Laboratories, Inc.;Harborside Financial Center, Plaza V;Jersey City, New Jersey, 07311 | October 21, 2010 | |
BCL-005 (fused (hybrid) melanoma-dendritic cells) | Metastatic Melanoma | Brucells SA;Rue de Ransbeekstraat 310;Brussel | October 21, 2010 | |
Ensituximab | Pancreatic cancer | Neogenix Oncology, Inc.;9700 Great Seneca Highway;Rockville, Maryland, 20850 | October 21, 2010 | |
N-acetylcysteine | Apnea of prematurity | Galleon Pharmaceuticals;213 Witmer Road;Horsham, Pennsylvania, 19044 | October 21, 2010 | |
Bevacizumab | Hereditary hemorrhagic telangiectasia | Terence M. Davidson, MD;UCSD Medical Center;San Diego, California, 92103 | October 21, 2010 | |
Algenpantucel-L | Pancreatic cancer | NewLink Genetics Corporation;2503 S. Loop Drive;Ames, Iowa, 50010 | October 21, 2010 | |
Alpha-tocotrienol quinone | Inherited mitochondrial respiratory chain diseases | Edison pharmaceuticals, Inc.;350 N. Bernardo Ave.;Mountain View, California, 94043 | October 21, 2010 | |
Lucinactant | Cystic fibrosis | Windtree Therapeutics, Inc.;2600 Kelly Road, Suite 100;Warrington, Pennsylvania, 18976 | October 21, 2010 | |
(S)-10-[(dimethylamino)methyl]-4-ethyl-9hydroxy-4-O-[a-(2″,4″,5″,7″-tetranitro-9″-fluorenylideneaminooxy)propionyl]- 1H-pyrano[3′,4′,6′,7′,] indolizino [1,2-B]-quinoline-3, 14-(4H, 12H)-dione, hydrochloride | Hepatocellular Carcinoma | TLC Biopharmaceuticals, Inc.;432 N Canal St, Suite 20;South San Francisco, California, 94080 | October 6, 2010 | |
(S)-10-[(dimethylamino)methyl]-4-ethyl-9-hydroxy-4-O-[alpha-(2”, 4”, 5”, 7”-tetranitro-9”-fluorenylideneaminooxy)propionyl]-1H-pyrano[3′, 4′, 6′, 7′]indolizino[1,2-beta]-quinoline-3, 14-(4H), 12H)-dione, hydrochloride | Hepatocellular Carcinoma | TLC Biopharmaceuticals B.V. | October 1, 2010 | |
MOD-423 hGH analogue | Growth hormone deficiency | Pfizer Inc.;445 Eastern Point Road;Groton, Connecticut, 06340 | September 29, 2010 | |
Ecopipam hydrochloride | Tourette syndrome | Psyadon Pharmaceuticals, Inc.;20451 Seneca Meadows Parkway;Germantown, Maryland, 20876 | September 29, 2010 | |
2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione | Idiopathic pulmonary fibrosis | GenKyoTex S.A.;14 Chemin des Aulx;Geneva | September 21, 2010 |